Florian Sandron

Mr. Florian Sandron

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Université Paris-Saclay, Evry, France
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2020 in EMBO Molecular Medicine
Verified
Journal Article
Open access
AKAriane Kröll‐Hermi
Ariane Kröll‐Hermi
FEFrédéric Ebstein
Frédéric Ebstein
CSCorinne Stoetzel
Corinne Stoetzel
VGVéronique Geoffroy
Véronique Geoffroy
ESElise Schaefer
Elise Schaefer
HDHélène Dollfus
Hélène Dollfus
The ubiquitin–proteasome system degrades ubiquitin‐modified proteins to maintain protein homeostasis and to control signalling. Whole‐genome sequencing of patients with severe deafness and early‐onset cataracts as part of a neurological, sensorial and cutaneous novel syndrome identified a unique deep intronic homozygous variant in the PSMC3 gene, encoding the proteasome ATPase subunit Rpt5, which lead to the transcription of a cryptic exon. The proteasome content and activity in patient's fibroblasts was however unaffected. Nevertheless, patient's cells exhibited impaired protein homeostasis characterized by accumulation of ubiquitinated proteins suggesting severe proteotoxic stress. Indeed, the TCF11/Nrf1 transcriptional pathway allowing proteasome recovery after proteasome inhibition is permanently activated in the patient's fibroblasts. Upon chemical proteasome inhibition, this pathway was however impaired in patient's cells, which were unable to compensate for proteotoxic stress although a higher proteasome content and activity. Zebrafish modelling for knockout in PSMC3 remarkably reproduced the human phenotype with inner ear development anomalies as well as cataracts, suggesting that Rpt5 plays a major role in inner ear, lens and central nervous system development.

5 April 2018 in PLOS ONE
Verified
Journal Article
Open access
EBEric Bonnet
Eric Bonnet
MMMarie-Laure Moutet
Marie-Laure Moutet
CBCéline Baulard
Céline Baulard
DBDelphine Bacq-Daian
Delphine Bacq-Daian
FSFlorian Sandron
Florian Sandron
Jean-François DeleuzeJean-François Deleuze
Jean-François Deleuze
Next-generation sequencing (NGS) studies are becoming routinely used for the detection of novel and clinically actionable DNA variants at a pangenomic scale. Such analyses are now used in the clinical practice to enable precision medicine. Formalin-fixed paraffin-embedded (FFPE) tissues are still one of the most abundant source of cancer clinical specimen, unfortunately this method of preparation is known to degrade DNA and therefore compromise subsequent analysis. Some studies have reported that variant detection can be performed on FFPE samples sequenced with NGS techniques, but few or none have done an in-depth coverage analysis and compared the influence of different state-of-the-art FFPE DNA extraction kits on the quality of the variant calling. Here, we generated 42 human whole-exome sequencing data sets from fresh-frozen (FF) and FFPE samples. These samples include normal and tumor tissues from two different organs (liver and colon), that we extracted with three different FFPE extraction kits (QIAamp DNA FFPE Tissue kit and GeneRead DNA FFPE kit from Qiagen, Maxwell™ RSC DNA FFPE Kit from Promega). We determined the rate of concordance of called variants between matched FF and FFPE samples on all common variants (representing at least 86% of the total number of variants for SNVs). The concordance rate is very high between all matched FF / FFPE pairs, with equivalent values for the three kits we analyzed. On the other hand, when looking at the difference between the total number of variants in FF and FFPE, we find a significant variation for the three different FFPE DNA extraction kits. Coverage analysis shows that FFPE samples have less good indicators than FF samples, yet the coverage quality remains above accepted thresholds. We detect limited but statistically significant variations in coverage indicator values between the three FFPE extraction kits. Globally, the GeneRead and QIAamp kits have better variant calling and coverage indicators than the Maxwell kit on the samples used in this study, although this kit performs better on some indicators and has advantages in terms of practical usage. Taken together, our results confirm the potential of FFPE samples analysis for clinical genomic studies, but also indicate that the choice of a FFPE DNA extraction kit should be done with careful testing and analysis beforehand in order to maximize the accuracy of the results.

4 August 2015 in Theoretical and Applied Genetics
Verified
Journal Article
Closed access
PDF file
BMBrigitte Mangin
Brigitte Mangin
FSFlorian Sandron
Florian Sandron
KHKarine Henry
Karine Henry
BDBrigitte Devaux
Brigitte Devaux
GWGlenda Willems
Glenda Willems
EGEllen Goudemand
Ellen Goudemand

Verified
Journal Article
Open access
PDF file
AKAdella Karam
Adella Karam
CDClarisse Delvallée
Clarisse Delvallée
AEAlejandro ESTRADA-CUZCANO
Alejandro ESTRADA-CUZCANO
VGVéronique Geoffroy
Véronique Geoffroy
JLJean-Baptiste Lamouche
Jean-Baptiste Lamouche
JMJean Muller
Jean Muller
Bardet–Biedl syndrome (BBS) is an autosomal recessive ciliopathy that affects multiple organs, leading to retinitis pigmentosa, polydactyly, obesity, renal anomalies, cognitive impairment, and hypogonadism. Until now, biallelic pathogenic variants have been identified in at least 24 genes delineating the genetic heterogeneity of BBS. Among those, BBS5 is a minor contributor to the mutation load and is one of the eight subunits forming the BBSome, a protein complex implied in protein trafficking within the cilia. This study reports on a European BBS5 patient with a severe BBS phenotype. Genetic analysis was performed using multiple next-generation sequencing (NGS) tests (targeted exome, TES and whole exome, WES), and biallelic pathogenic variants could only be identified using whole-genome sequencing (WGS), including a previously missed large deletion of the first exons. Despite the absence of family samples, the biallelic status of the variants was confirmed. The BBS5 protein’s impact was confirmed on the patient’s cells (presence/absence and size of the cilium) and ciliary function (Sonic Hedgehog pathway). This study highlights the importance of WGS and the challenge of reliable structural variant detection in patients’ genetic explorations as well as functional tests to assess a variant’s pathogenicity.

20 February 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
EGELENA GARGAUN
ELENA GARGAUN
SFSESTINA FALCONE
SESTINA FALCONE
GSGuilhem Solé
Guilhem Solé
JDJulien Durigneux
Julien Durigneux
AUAndoni Urtizberea
Andoni Urtizberea
FPFrance Piétri-Rouxel
France Piétri-Rouxel
In skeletal muscle, long noncoding RNAs (lncRNAs) are involved in dystrophin protein stabilization but also in the regulation of myocytes proliferation and differentiation. Hence, they could represent promising therapeutic targets and/or biomarkers for Duchenne and Becker muscular dystrophy (DMD/BMD). DMD and BMD are X-linked myopathies characterized by a progressive muscular dystrophy with or without dilatative cardiomyopathy. Two-thirds of DMD gene mutations are represented by deletions, and 63% of patients carrying DMD deletions are eligible for 45 to 55 multi-exons skipping (MES), becoming BMD patients (BMDΔ45-55). We analyzed the genomic lncRNA presence in 38 BMDΔ45-55 patients and characterized the lncRNA localized in introns 44 and 55 of the DMD gene. We highlighted that all four lncRNA are differentially expressed during myogenesis in immortalized and primary human myoblasts. In addition, the lncRNA44s2 was pointed out as a possible accelerator of differentiation. Interestingly, lncRNA44s expression was associated with a favorable clinical phenotype. These findings suggest that lncRNA44s2 could be involved in muscle differentiation process and become a potential disease progression biomarker. Based on these results, we support MES45-55 therapy and propose that the design of the CRISPR/Cas9 MES45-55 assay consider the lncRNA sequences bordering the exonic 45 to 55 deletion.

8 September 2025 in Bioinformatics
Verified
Journal Article
Open access
MMMallek Mziou-Sallami
Mallek Mziou-Sallami
PRPierrick Roger
Pierrick Roger
AGArnaud Gloaguen
Arnaud Gloaguen
CDClaire Dandine-Roulland
Claire Dandine-Roulland
TNThierry Jiogho Ngaho
Thierry Jiogho Ngaho
VMVincent Meyer
Vincent Meyer
Motivation: Graph Neural Network (GNN) models have emerged in many fields and notably for biological networks constituted by genes or proteins and their interactions. The majority of enrichment study methods apply over-representation analysis and gene/protein set scores according to the existing overlap between pathways. Such methods neglect knowledges coming from the interactions between the gene/protein sets. Here, we introduce a novel GNN-based enrichment analysis method called GNNenrich. GNNenrich, through multiple levels of embedding that integrate protein sequence properties and interactions network, establishes functional relationship to support biological interpretation. Results: GNNenrich have been tested and compared to Over-Representation Analysis technique (g: Profiler) and graph-based method (EnrichNet). It demonstrates the capacity to reproduce results provided by others approaches and offers new perspectives for interpretation, returning relevant results supported by Protein–Protein Interactions (PPIs). Availability and implementation: Source code is available at https://gitlab.com/cnrgh/gnn-enrich/gnn-enrich-article-demo.